[go: up one dir, main page]

NO743588L - Bis-tetrahydropyranyl ether for use as an intermediate for the preparation of a physiologically active β-biphenyl ester of an E- or F-series prostaglandin analogue. - Google Patents

Bis-tetrahydropyranyl ether for use as an intermediate for the preparation of a physiologically active β-biphenyl ester of an E- or F-series prostaglandin analogue.

Info

Publication number
NO743588L
NO743588L NO743588A NO743588A NO743588L NO 743588 L NO743588 L NO 743588L NO 743588 A NO743588 A NO 743588A NO 743588 A NO743588 A NO 743588A NO 743588 L NO743588 L NO 743588L
Authority
NO
Norway
Prior art keywords
bis
preparation
physiologically active
tetrahydropyranyl ether
prostaglandin analogue
Prior art date
Application number
NO743588A
Other languages
Norwegian (no)
Other versions
NO146280C (en
NO146280B (en
Inventor
Jasit Singh Bindra
Michael Ross Johnson
Thomas Ken Schaaf
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO743588L publication Critical patent/NO743588L/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO146280B publication Critical patent/NO146280B/en
Publication of NO146280C publication Critical patent/NO146280C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NO743588A 1972-11-08 1974-10-03 BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES NO146280C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481572A 1972-11-08 1972-11-08

Publications (3)

Publication Number Publication Date
NO743588L true NO743588L (en) 1974-05-09
NO146280B NO146280B (en) 1982-05-24
NO146280C NO146280C (en) 1982-09-01

Family

ID=23178143

Family Applications (2)

Application Number Title Priority Date Filing Date
NO4290/73A NO145437C (en) 1972-11-08 1973-11-07 ANALOGY PROCEDURE FOR PREPARING A PHYSIALLY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES
NO743588A NO146280C (en) 1972-11-08 1974-10-03 BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO4290/73A NO145437C (en) 1972-11-08 1973-11-07 ANALOGY PROCEDURE FOR PREPARING A PHYSIALLY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES

Country Status (24)

Country Link
JP (1) JPS5644068B2 (en)
AR (2) AR204816A1 (en)
AT (1) AT347607B (en)
BE (1) BE807047A (en)
CA (1) CA1027559A (en)
CH (1) CH601222A5 (en)
CS (1) CS188175B2 (en)
DD (2) DD111370A5 (en)
DE (2) DE2365999A1 (en)
ES (2) ES420326A1 (en)
FI (1) FI58116C (en)
FR (2) FR2205339B1 (en)
GB (1) GB1456511A (en)
HU (2) HU171818B (en)
IE (1) IE39686B1 (en)
IL (1) IL43553A (en)
IN (1) IN139905B (en)
NL (1) NL7315240A (en)
NO (2) NO145437C (en)
PH (2) PH15504A (en)
SE (2) SE420198B (en)
SU (2) SU538659A3 (en)
YU (2) YU287973A (en)
ZA (1) ZA738593B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361381A1 (en) * 1972-07-13 1978-03-10 Pfizer (15)-(Hetero) aryl prostaglandin analogues - with long-lasting prostaglandin-like activity
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2
DE2737807A1 (en) * 1976-08-27 1978-03-09 Pfizer C LOW 1 -P-BIPHENYLESTER OF OMEGA-PENTANORPROSTAGLANDINES
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
DD113211A5 (en) 1975-05-20
IE39686B1 (en) 1978-12-06
JPS5644068B2 (en) 1981-10-16
NO145437C (en) 1982-03-24
NO146280C (en) 1982-09-01
SU1021340A3 (en) 1983-05-30
FR2275452A1 (en) 1976-01-16
ZA738593B (en) 1974-10-30
ATA937173A (en) 1978-05-15
IL43553A0 (en) 1974-03-14
DD111370A5 (en) 1975-02-12
CA1027559A (en) 1978-03-07
SE7704369L (en) 1977-04-15
IE39686L (en) 1974-05-08
CS188175B2 (en) 1979-02-28
IL43553A (en) 1979-10-31
AU6222573A (en) 1975-05-08
PH15504A (en) 1983-02-03
FI58116C (en) 1980-12-10
AR204816A1 (en) 1976-03-05
GB1456511A (en) 1976-11-24
DE2365999A1 (en) 1977-05-12
DE2355042A1 (en) 1974-05-22
YU264480A (en) 1983-04-27
CH601222A5 (en) 1978-06-30
ES434687A1 (en) 1976-12-16
PH13794A (en) 1980-10-01
HU171945B (en) 1978-04-28
NL7315240A (en) 1974-05-10
NO145437B (en) 1981-12-14
BE807047A (en) 1974-05-08
YU287973A (en) 1982-02-25
FI58116B (en) 1980-08-29
AR202311A1 (en) 1975-05-30
JPS49100060A (en) 1974-09-20
SU538659A3 (en) 1976-12-05
HU171818B (en) 1978-03-28
IN139905B (en) 1976-08-14
AT347607B (en) 1979-01-10
SE420198B (en) 1981-09-21
NO146280B (en) 1982-05-24
ES420326A1 (en) 1976-03-16
FR2205339B1 (en) 1980-01-04
FR2275452B1 (en) 1977-12-16
FR2205339A1 (en) 1974-05-31

Similar Documents

Publication Publication Date Title
SE418080B (en) CFYCLOPROPANCARBOXYLIC ACID ESTERS FOR USE AS INSECTICIDE
NO141752C (en) Substituted acetic acid esters for use as pesticides
SE400280B (en) 2-HALOGEN-4-SUBSTITUTED-6,7,8-TRIALCOXIKINAZOLINES FOR USE AS AN INTERMEDIATE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 2-SUBSTITUTED-4-AMINO-6,7,8-TRIALKOXIKINAZ
CA1010055A (en) PREPARATION OF OPTICALLY ACTIVE ESTERS OF .alpha.-AMINO ACIDS
NO138335C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE ALKANOLAMINES
NO140381C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE ARYLPIPERAZINES
NO142670C (en) BENZYLPENICILLINESTERS FOR USE AS BASIC MATERIAL IN THE PREPARATION OF A THERAPEUTIC ACTIVE ESTER OF ALFA-AMINOBENZYLPENICILLINES
SE422051B (en) ALKYNYLYCYLOPROPANCARBOXYLIC ACID ESTERS FOR USE AS INSECTICIDES
SE435289B (en) O-SUBSTITUTED 7 BETA-AMINO-3-CEFEM-3-OL-4-CARBONIC ACID DERIVATIVES FOR USING AS INTERMEDIATE FOR THE PREPARATION OF O-SUBSTITUTED 7 BETA-ACYLAMINO-3-CEFEM-3-OL-4-OL-4-OL-4
NO141717C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE TRIAZOLOPYRIDAZINES
NO149139C (en) DIMETHYLOX OXPHOSPHONATES FOR USE AS BASIC MATERIAL IN THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLANDINES
SE417957B (en) OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGUES FOR USE AS ANTIFERTILITY AGENT
SE384359B (en) PROCEDURE FOR THE PREPARATION OF A URANDIOXI-RICH COMPOSITION FROM URANEHEXAFLUORIDE IN THE PRESENCE OF AN ACTIVE FLAME
SE388851B (en) L-ASPARYLAMINOMALONIC ACID ALKYLPHENE CYLDYSTERS AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF FOR USE AS DETERGENTS
NO142033C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE ISOPROPYLAMINO-3-PHENOXYPROPANOLS
DK137333B (en) Process for the preparation of an optically active (+) - lactone.
NO743492L (en) Substituted cyclopentane derivative for use as an intermediate in the preparation of a physiologically active prostaglandin compound of the E or F series.
NO137823C (en) PROCEDURE FOR PREPARING AS ISOPROPYL ALCOHOL AS A FUEL ADDITION
NO743588L (en) Bis-tetrahydropyranyl ether for use as an intermediate for the preparation of a physiologically active β-biphenyl ester of an E- or F-series prostaglandin analogue.
SE395592B (en) INSECTICIDAL PREPARATION CONTAINING AS AN ACTIVE SUBSTANCE CERTAIN BENZYLIDENESMICARBAZIDES
NO144928C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE ZANTINE DERIVATIVES.
NO145383C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED INDOLS.
CA992544A (en) Process for the preparation of new oxyacetic ether derivatives of ortho-thymotic esters
NO141121C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE MORPHOLINE DERIVATIVES
AU469908B2 (en) Prostaglandin analogs